XTL Biopharmaceuticals Ltd. Sponsored ADR
(NASDAQ : XTLB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.12%194.251.2%$601.86m
GILDGilead Sciences, Inc.
-0.71%67.090.9%$499.75m
CELGCelgene Corporation
1.45%67.721.2%$483.56m
BIIBBiogen Inc.
-0.22%318.781.3%$465.13m
ILMNIllumina, Inc.
2.87%309.723.5%$397.69m
REGNRegeneron Pharmaceuticals, Inc.
1.37%341.912.6%$295.61m
VRTXVertex Pharmaceuticals Incorporated
0.80%161.031.9%$260.58m
AAgilent Technologies, Inc.
0.96%68.171.5%$218.02m
ALXNAlexion Pharmaceuticals, Inc.
2.24%119.442.0%$205.05m
SRPTSarepta Therapeutics, Inc.
0.00%117.1715.4%$146.00m
LGNDLigand Pharmaceuticals Incorporated
2.26%152.2323.1%$140.50m
TSROTESARO, Inc.
-3.72%40.9014.4%$133.57m
EXASExact Sciences Corporation
1.85%65.9325.3%$132.93m
NKTRNektar Therapeutics
-2.57%37.145.6%$118.84m
INCYIncyte Corporation
0.98%64.212.5%$114.06m

Company Profile

XTL Biopharmaceuticals Ltd is a biopharmaceutical company, which engages in the acquisition and development of pharmaceutical drugs. Its drug development program focuses on the treatment of systemic lupus erythematosus. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel.